Clayton Financial Group LLC Moderna, Inc. Transaction History
Clayton Financial Group LLC
- $196 Billion
- Q4 2025
A detailed history of Clayton Financial Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Clayton Financial Group LLC holds 21 shares of MRNA stock, worth $519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21Holding current value
$519% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
848Shares Held
256MCall Options Held
39.6MPut Options Held
43.1M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO20.6MShares$510 Million0.45% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...